You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

INCB39110

Showing 1 - 23 of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelofibrosis Trial in Canada, United States (itacitinib)

Recruiting
  • Myelofibrosis
  • Aurora, Colorado
  • +4 more
Mar 8, 2022

Lymphoma Trial in United States (itacitinib, ibrutinib)

Completed
  • Lymphoma
  • Scottsdale, Arizona
  • +20 more
Nov 14, 2022

Cytokine Release Syndrome Trial in United States (Itacitinib, Immune effector cell therapy, Placebo)

Recruiting
  • Cytokine Release Syndrome
  • Miami, Florida
  • +9 more
Oct 25, 2022

Bronchiolitis Obliterans Syndrome Trial in Belgium, Canada, United States (Itacitinib)

Active, not recruiting
  • Bronchiolitis Obliterans Syndrome
  • Los Angeles, California
  • +8 more
Oct 14, 2022

Myelofibrosis, Polycythemia Vera, Thrombocythemia Trial in Worldwide (itacitinib)

Active, not recruiting
  • Myelofibrosis
  • +2 more
  • New Orleans, Louisiana
  • +20 more
Aug 25, 2022

Hematologic Malignancies Trial in Worldwide (Itacitinib, Calcineurin inhibitor)

Terminated
  • Hematologic Malignancies
  • Aurora, Colorado
  • +16 more
Apr 29, 2022

STAT1 Gain-of-Function Disease Trial (Itacitinib)

Available
  • STAT1 Gain-of-Function Disease
  • (no location specified)
Sep 30, 2022

Lung Cancer Trial in Worldwide (Itacitinib, Osimertinib)

Active, not recruiting
  • Lung Cancer
  • La Jolla, California
  • +30 more
Mar 8, 2022

MPN (Myeloproliferative Tumors) Trial in Australia, Canada, United States (itacitinib)

Completed
  • MPN (Myeloproliferative Neoplasms)
  • Birmingham, Alabama
  • +21 more
Aug 25, 2021

Colorectal Cancer (CRC), Endometrial Cancer, Melanoma Trial in United States (Pembrolizumab, itacitinib, INCB050465)

Completed
  • Colorectal Cancer (CRC)
  • +10 more
  • San Francisco, California
  • +16 more
Mar 30, 2022

Chronic Graft-versus-host Disease Trial in Worldwide (Itacitinib, Placebo, Methylprednisolone)

Active, not recruiting
  • Chronic Graft-versus-host Disease
  • Tucson, Arizona
  • +132 more
Oct 17, 2022

Acute Graft-versus-host Disease Trial in Worldwide (Itacitinib, Corticosteroids)

Terminated
  • Acute Graft-versus-host Disease
  • Duarte, California
  • +37 more
Feb 17, 2021

Graft-versus-host Disease (GVHD) Trial in Worldwide (Itacitinib, Placebo, Prednisone)

Completed
Has Results
  • Graft-versus-host Disease (GVHD)
  • La Jolla, California
  • +128 more
Jul 13, 2021

Acute Graft-versus-host Disease Trial in Japan (Itacitinib, Corticosteroid)

Completed
  • Acute Graft-versus-host Disease
  • Anjo-Shi, Aichi, Japan
  • +16 more
Mar 2, 2020

Moderate to Severe Ulcerative Colitis Trial (Itacitinib, Placebo)

Withdrawn
  • Moderate to Severe Ulcerative Colitis
  • (no location specified)
Dec 4, 2019

Solid Tumors, Pancreatic Cancer Trial in United States (itacitinib, Gemcitabine, nab-paclitaxel)

Completed
  • Solid Tumors
  • Pancreatic Cancer
  • Scottsdale, Arizona
  • +7 more
Jul 16, 2019

Solid Tumors Trial in United States (Itacitinib, Epacadostat, INCB050465)

Terminated
  • Solid Tumors
  • Duarte, California
  • +10 more
Sep 23, 2019

Plaque Psoriasis Trial in Canada, United States (Itacitinib, Placebo)

Completed
  • Plaque Psoriasis
  • Hot Springs, Arkansas
  • +8 more
Mar 8, 2019

Graft-versus-host Disease (GVHD) Trial in United States (Itacitinib (200 mg), Itacitinib (300 mg), prednisone or

Completed
  • Graft-versus-host Disease (GVHD)
  • Itacitinib (200 mg)
  • +2 more
  • Duarte, California
  • +22 more
Mar 6, 2019

Solid Tumors and Hematologic Malignancy, NSCLC (Non-small Cell Lung Carcinoma) Trial in Ogden (Itacitinib, erlotinib, )

Withdrawn
  • Solid Tumors and Hematologic Malignancy
  • NSCLC (Non-small Cell Lung Carcinoma)
  • Ogden, Utah
    (unnamed)
Mar 6, 2019

Pruritis Trial (INCB039110)

Withdrawn
  • Pruritis
  • (no location specified)
May 10, 2019

Rheumatoid Arthritis Trial in Puerto Rico, United States (Itacitinib, Itacitinib Placebo)

Completed
  • Rheumatoid Arthritis
  • Palm Desert, California
  • +17 more
Mar 8, 2019

NSCLC (Non-small Cell Lung Carcinoma) Trial in United States (Itacitinib, docetaxel)

Terminated
  • NSCLC (Non-small Cell Lung Carcinoma)
  • Hot Springs, Arizona
  • +15 more
Jan 18, 2018